Effects of remoxipride, an atypical antipsychotic, on cocaine self-administration in the rat using fixed- and progressive-ratio schedules of reinforcement

James A. Bourland, Edward D French

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Remoxipride, a selective D2-dopamine receptor antagonist with preferential activity for mesolimbic-mediated behaviors, was assessed for its potential to block cocaine self-administration. The effects of remoxipride (RMX) were evaluated using fixed-ratio-1 (FR-1) and progressive-ratio (PR) schedules of reinforcement. On FR-1, RMX pretreatment increased the rate of cocaine injections, while on a PR, breaking points were reduced. Daily RMX treatment also resulted in breaking point reductions, but the decreases in cocaine's reinforcing potency did not result in extinction of cocaine intake and were not sustained upon cessation of RMX. Thus, RMX can reduce the rewarding effects of cocaine, and if safely tolerated over sustained periods of treatment it, or drugs with a similar pharmacological profile, could provide a therapeutic adjunct in the treatment of cocaine addiction.

Original languageEnglish (US)
Pages (from-to)111-114
Number of pages4
JournalDrug and Alcohol Dependence
Volume40
Issue number2
DOIs
StatePublished - 1995

Fingerprint

Remoxipride
self-administration
Reinforcement Schedule
Self Administration
Cocaine
reinforcement
Antipsychotic Agents
Rats
Reinforcement
addiction
drug
Cocaine-Related Disorders
Therapeutics
Pharmacology
Injections

Keywords

  • Cocaine
  • Progressive-ratio
  • Reinforcement
  • Remoxipride
  • Self-administration

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Pharmacology
  • Toxicology
  • Medicine(all)
  • Behavioral Neuroscience
  • Health(social science)

Cite this

@article{0316d942596e4b6a98618a1494f76d7c,
title = "Effects of remoxipride, an atypical antipsychotic, on cocaine self-administration in the rat using fixed- and progressive-ratio schedules of reinforcement",
abstract = "Remoxipride, a selective D2-dopamine receptor antagonist with preferential activity for mesolimbic-mediated behaviors, was assessed for its potential to block cocaine self-administration. The effects of remoxipride (RMX) were evaluated using fixed-ratio-1 (FR-1) and progressive-ratio (PR) schedules of reinforcement. On FR-1, RMX pretreatment increased the rate of cocaine injections, while on a PR, breaking points were reduced. Daily RMX treatment also resulted in breaking point reductions, but the decreases in cocaine's reinforcing potency did not result in extinction of cocaine intake and were not sustained upon cessation of RMX. Thus, RMX can reduce the rewarding effects of cocaine, and if safely tolerated over sustained periods of treatment it, or drugs with a similar pharmacological profile, could provide a therapeutic adjunct in the treatment of cocaine addiction.",
keywords = "Cocaine, Progressive-ratio, Reinforcement, Remoxipride, Self-administration",
author = "Bourland, {James A.} and French, {Edward D}",
year = "1995",
doi = "10.1016/0376-8716(95)01187-0",
language = "English (US)",
volume = "40",
pages = "111--114",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Effects of remoxipride, an atypical antipsychotic, on cocaine self-administration in the rat using fixed- and progressive-ratio schedules of reinforcement

AU - Bourland, James A.

AU - French, Edward D

PY - 1995

Y1 - 1995

N2 - Remoxipride, a selective D2-dopamine receptor antagonist with preferential activity for mesolimbic-mediated behaviors, was assessed for its potential to block cocaine self-administration. The effects of remoxipride (RMX) were evaluated using fixed-ratio-1 (FR-1) and progressive-ratio (PR) schedules of reinforcement. On FR-1, RMX pretreatment increased the rate of cocaine injections, while on a PR, breaking points were reduced. Daily RMX treatment also resulted in breaking point reductions, but the decreases in cocaine's reinforcing potency did not result in extinction of cocaine intake and were not sustained upon cessation of RMX. Thus, RMX can reduce the rewarding effects of cocaine, and if safely tolerated over sustained periods of treatment it, or drugs with a similar pharmacological profile, could provide a therapeutic adjunct in the treatment of cocaine addiction.

AB - Remoxipride, a selective D2-dopamine receptor antagonist with preferential activity for mesolimbic-mediated behaviors, was assessed for its potential to block cocaine self-administration. The effects of remoxipride (RMX) were evaluated using fixed-ratio-1 (FR-1) and progressive-ratio (PR) schedules of reinforcement. On FR-1, RMX pretreatment increased the rate of cocaine injections, while on a PR, breaking points were reduced. Daily RMX treatment also resulted in breaking point reductions, but the decreases in cocaine's reinforcing potency did not result in extinction of cocaine intake and were not sustained upon cessation of RMX. Thus, RMX can reduce the rewarding effects of cocaine, and if safely tolerated over sustained periods of treatment it, or drugs with a similar pharmacological profile, could provide a therapeutic adjunct in the treatment of cocaine addiction.

KW - Cocaine

KW - Progressive-ratio

KW - Reinforcement

KW - Remoxipride

KW - Self-administration

UR - http://www.scopus.com/inward/record.url?scp=0029594124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029594124&partnerID=8YFLogxK

U2 - 10.1016/0376-8716(95)01187-0

DO - 10.1016/0376-8716(95)01187-0

M3 - Article

C2 - 8745132

AN - SCOPUS:0029594124

VL - 40

SP - 111

EP - 114

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 2

ER -